| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 12,046,000 | 11,276,000 | 9,087,000 | 10,899,000 | | Cost of Revenue | 10,386,000 | 9,737,000 | 8,165,000 | 10,493,000 | | | Gross Profit | 1,660,000 | 1,539,000 | 922,000 | 406,000 | | | Operating Expenses | | Research Development | 400,000 | 381,000 | 292,000 | 310,000 | | Selling General and Administrative | 804,000 | 662,000 | 444,000 | 458,000 | | Non Recurring | (100,000) | 714,000 | 67,000 | 1,072,000 | | Others | 108,000 | 112,000 | 22,000 | 24,000 | | | | Total Operating Expenses | 1,212,000 | 1,869,000 | 825,000 | 1,864,000 | | | | Operating Income or Loss | 448,000 | (330,000) | 97,000 | (1,458,000) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 819,000 | 32,000 | 9,000 | 54,000 | | Earnings Before Interest And Taxes | 1,491,000 | (176,000) | 171,000 | (1,408,000) | | Interest Expense | 488,000 | 525,000 | 154,000 | 192,000 | | Income Before Tax | 1,003,000 | (701,000) | 17,000 | (1,600,000) | | Income Tax Expense | 204,000 | (255,000) | (18,000) | (60,000) | | Minority Interest | (22,000) |
-
|
-
| (12,000) | | | | Net Income From Continuing Ops | 777,000 | (446,000) | 35,000 | (1,552,000) | | | Non-recurring Events | | Discontinued Operations | (4,000) | 114,000 |
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 773,000 | (332,000) | 35,000 | (1,552,000) | | Preferred Stock And Other Adjustments | (62,000) | (154,000) | (11,000) |
-
| | | Net Income Applicable To Common Shares | $711,000 | ($486,000) | $24,000 | ($1,552,000) |
|
0.34% Nasdaq 0.00%
Income Statement
